Open AccessAsymmetric Dimethylarginine Impairs Glucose Utilization via ROS/TLR4 Pathway in Adipocytes: an Effect Prevented by Vitamin E
Author(s) -
ZhiChun Yang,
Kuan-Song Wang,
Yan Wu,
Xiao-Qing Zou,
Yue-Yun Xiang,
Xiaoping Chen,
YuanJian Li
Publication year - 2009
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000227819
Subject(s) - asymmetric dimethylarginine , endocrinology , medicine , tlr4 , chemistry , vitamin d and neurology , vitamin , reactive oxygen species , signal transduction , microbiology and biotechnology , biochemistry , biology , arginine , amino acid
Asymmetric dimethylarginine (ADMA), the inhibitor of nitric oxide synthase (NOS), has been reported to be associated with glucose metabolism, but its mechanisms remain unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom